Bromhexine

Bromhexinum

For medical students2 min readUpdated 2026-10-10

Bromhexine is a mucolytic and expectorant drug that acts as a prodrug, metabolizing in the body into its active form, ambroxol. The medication is effective in treating respiratory tract disorders characterized by difficult clearance of viscous sputum.

Trade NamesSolvin, Bisolvon

Active MetaboliteAmbroxol

Clinical ApplicationRespiratory System Diseases

Side EffectsAllergies and Dyspepsia

General Characteristics and Biotransformation

The drug Bromhexinum is widely known under the trade names Solvin and Bisolvon. A key feature of its pharmacokinetics is that the substance functions as a prodrug. Upon entering the human body, it undergoes metabolic conversion to yield the pharmacologically active metabolite — ambroxol.

Pharmacodynamics

The pharmacological effects of the drug are mediated by its ability to liquefy secretions and facilitate their removal. In addition to its primary mucolytic action, which is achieved through the formation of ambroxol, Bromhexinum exhibits its own specific antitussive effect.

Clinical Application and Administration

The primary indications for use include various pathological conditions of the respiratory system accompanied by difficult clearance of viscous sputum:

Bronchitis and tracheobronchitis
Pneumonia
Bronchiectasis
Bronchial asthma

Various routes of administration are used to deliver the drug: oral administration (tablets and solutions), and in severe cases, intravenous administration.

Safety Profile

Overall, the medication is characterized by good patient tolerance. However, potential adverse reactions should be considered in clinical practice:

Allergic manifestations — skin rash or rhinitis.
Dyspeptic symptoms — may occur with prolonged courses of the drug.

Mnemonic

Bromhexine converts to Ambroxol: BA (Bromhexine -> Ambroxol).

Frequently asked questions

What is the biochemical mechanism of the mucolytic action of bromhexine?

Bromhexine is a prodrug whose mechanism of action is linked to biotransformation in the body into the active metabolite — ambroxol. The main pharmacodynamic effects of the drug include:

Sputum liquefaction — decreasing the viscosity of bronchial secretions to facilitate clearance.
Stimulation of surfactant synthesis — production of surface-active material.

In addition to mucolytic and expectorant effects, the drug has its own antitussive action. It is administered orally or intravenously for diseases with impaired clearance of viscous sputum.

What are the absolute contraindications to prescribing bromhexine?

Contraindications for prescribing bromhexine include pregnancy and breastfeeding. For drugs containing bromhexine or ambroxol, contraindications are specifically noted for the first trimester of pregnancy and the breastfeeding period. These restrictions also apply to combination drugs containing bromhexine, guaifenesin, and salbutamol.

Which drug classes should bromhexine not be combined with?

Bromhexine is strictly contraindicated in combination with antitussive agents. Since bromhexine is an expectorant and mucolytic drug that promotes sputum clearance, suppressing the cough reflex is unacceptable. Antitussive agents that must not be combined with bromhexine include:

Glaucine — central-acting drug (non-narcotic).
Prenoxdiazine — peripheral-acting drug.
Oxeladine — cough-suppressant agent.
Codeine — central-acting drug (narcotic).

How does bromhexine affect endogenous surfactant production?

Bromhexine stimulates surfactant production. This effect is also characteristic of its active form, ambroxol. Surfactant prevents alveolar collapse and possesses bactericidal properties.

Is bromhexine an active substance on its own?

No, the substance acts as a prodrug. It exerts its main pharmacological properties after conversion into its active metabolite, ambroxol.

What are the main effects of this drug?

It provides prominent mucolytic and expectorant action, and also possesses its own antitussive effect.

In which clinical situations is bromhexine prescribed?

It is used for conditions accompanied by difficult clearance of viscous sputum: bronchitis, tracheobronchitis, pneumonia, bronchiectasis, and bronchial asthma.

What are the possible side effects with prolonged use?

Allergic reactions such as skin rash and rhinitis are possible, and prolonged use may also lead to dyspeptic disorders.

Go deeper

Enzymatic mechanisms of the metabolic transformation of bromhexine to ambroxol
Comparative analysis of the mucolytic activity of bromhexine and other secretolytics
Pharmacokinetic features of oral versus intravenous administration routes
Patient management tactics during dyspeptic disorders in long-term therapy
Criteria for choosing between bromhexine and pure ambroxol in clinical practice